HealthDay -- Even as they digest the latest news on what dose of the clot-dissolving drug Plavix is best during angioplasty, cardiologists are looking at the next generation of clot-busters that could replace Plavix. Clot-dissolving therapy was the big buzz among cardiologists at last week’s Transcatheter Cardiovascular Therapeutics conference in San Francisco.
